These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 19144793

  • 21. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010.
    Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML, Reyes R, Lizama A, Diras D, Mathew A, Camacho EJ, Monforte MN, Chen TH, Mahamud A, Kutty PK, Hickman C, Bellini WJ, Seward JF, Gallagher K, Fiebelkorn AP.
    Pediatr Infect Dis J; 2013 Apr; 32(4):374-80. PubMed ID: 23099425
    [Abstract] [Full Text] [Related]

  • 22. Epidemiological characteristics and serological survey of mumps 15 years after MMR vaccine was included in the immunization program.
    Gong X, Fang Q, Zheng W, Lai S, Xu W, Yin Z.
    J Med Virol; 2024 Aug; 96(8):e29856. PubMed ID: 39135476
    [Abstract] [Full Text] [Related]

  • 23. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape.
    Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, Duprex WP.
    J Virol; 2012 Jan; 86(1):615-20. PubMed ID: 22072778
    [Abstract] [Full Text] [Related]

  • 24. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
    Gouma S, Ten Hulscher HI, Schurink-van 't Klooster TM, de Melker HE, Boland GJ, Kaaijk P, van Els CACM, Koopmans MPG, van Binnendijk RS.
    Vaccine; 2016 Jul 29; 34(35):4166-4171. PubMed ID: 27372154
    [Abstract] [Full Text] [Related]

  • 25. Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report.
    Fields VS, Safi H, Waters C, Dillaha J, Capelle L, Riklon S, Wheeler JG, Haselow DT.
    Lancet Infect Dis; 2019 Feb 29; 19(2):185-192. PubMed ID: 30635255
    [Abstract] [Full Text] [Related]

  • 26. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults.
    Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF.
    CMAJ; 2006 Aug 29; 175(5):483-8. PubMed ID: 16940266
    [Abstract] [Full Text] [Related]

  • 27. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance.
    Pebody RG, Gay NJ, Hesketh LM, Vyse A, Morgan-Capner P, Brown DW, Litton P, Miller E.
    Vaccine; 2002 Jan 15; 20(7-8):1134-40. PubMed ID: 11803074
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M, Palmu AA, Syrjänen RK, Lahdenkari M, Ruokokoski E, Davidkin I, Vaarala O, Melin M.
    J Infect Dis; 2016 Jun 15; 213(12):2005-13. PubMed ID: 26908733
    [Abstract] [Full Text] [Related]

  • 31. Mumps outbreak and laboratory diagnosis.
    Maillet M, Bouvat E, Robert N, Baccard-Longère M, Morel-Baccard C, Morand P, Vabret A, Stahl JP.
    J Clin Virol; 2015 Jan 15; 62():14-9. PubMed ID: 25542464
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City.
    Livingston KA, Rosen JB, Zucker JR, Zimmerman CM.
    Vaccine; 2014 Jan 09; 32(3):369-74. PubMed ID: 24252695
    [Abstract] [Full Text] [Related]

  • 35. A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults.
    Kaaijk P, Wijmenga-Monsuur AJ, van Houten MA, Veldhuijzen IK, Ten Hulscher HI, Kerkhof J, van der Klis FR, van Binnendijk RS.
    J Infect Dis; 2020 Mar 02; 221(6):902-909. PubMed ID: 31112277
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program.
    Ngaovithunvong V, Wanlapakorn N, Tesapirat L, Suratannon N, Poovorawan Y.
    J Infect Dev Ctries; 2016 Aug 02; 10(7):735-40. PubMed ID: 27482805
    [Abstract] [Full Text] [Related]

  • 38. [Study of mumps immunity after administrating measles-mumps-rubella vaccine among children aged 2-7 years old in Jiangsu Province in 2015].
    Liu YB, Hu Y, Deng XY, Wang ZG, Sun X, Lu PS, Guo HX, Tang FY, Zhou MH.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul 06; 51(7):593-597. PubMed ID: 28693082
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.